Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限公司

Pay for financial year ended 2018-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Chan, Peter Kin Sang 陳健生 INED 4 4
2 Kwok, Wilson Chi Shing 郭志成 INED 4 4
3 Poon, Michael Lai Yin 潘禮賢 FD 13 13
4 Yeung, David Wai Chow 楊煒秋 INED 4 4
5 Zhang, Chunguang (1968) 張春光 CEO 234 18 32 284
6 Zhang, Shuguang (1970) 張曙光 Ch 193 21 26 240
Total 12 440 39 58 0 549

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2023-12-31 308 1,708 516 211 0 2,743 Report
2022-12-31 258 2,065 668 0 0 2,991 Report
2021-12-31 249 2,053 151 0 0 2,453 Report
2020-12-31 268 1,801 139 0 1,636 3,844 Report
2019-12-31 264 787 181 0 0 1,232 Report
2018-12-31 12 440 39 58 0 549 Report
Total 1,359 8,854 1,694 269 1,636 13,812

Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!


Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top